Article Versions Notes

Moser MJ, Hill-Batorski L, Bowen RA, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants. Vaccines. 2023; 11(6):1063. https://doi.org/10.3390/vaccines11061063

Moser, Michael J., Lindsay Hill-Batorski, Richard A. Bowen, Sarah M. Matejka, David Marshall, Yoshihiro Kawaoka, Gabriele Neumann, and Pamuk Bilsel. 2023. "Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants" Vaccines 11, no. 6: 1063. https://doi.org/10.3390/vaccines11061063

Moser, M. J., Hill-Batorski, L., Bowen, R. A., Matejka, S. M., Marshall, D., Kawaoka, Y., Neumann, G., & Bilsel, P. (2023). Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants. Vaccines, 11(6), 1063. https://doi.org/10.3390/vaccines11061063